Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-02-09 @ 4:09 PM
Study NCT ID:
NCT03427866
Status:
COMPLETED
Last Update Posted:
2025-07-29
First Post:
2018-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
Sponsor:
Massachusetts General Hospital
Organization: